Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea
European Archives of Oto-Rhino-Laryngology · 2025
DOI: 10.1007/s00405-024-09022-z ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Omer Faruk Calim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Faculty of Medicine, Istanbul Medipol University, Göztepe Mah. Atatürk Cad. No: 40/16, Beykoz, 34815, Istanbul, Tu…. Hauptthemen laut MEDLINE: Sialorrhea, Botulinum Toxins, Type A, Submandibular Gland, Parotid Gland. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to assess the effectiveness of four-duct ligation following Botulinum toxin-A injections into the parotid and submandibular glands in pediatric patients with sialorrhea resistant to nonsurgical treatments. Prior research has individually explored either surgical or Botulinum toxin interventions; however, the safety and efficacy of the combined approach to these treatments have yet to be documented. METHODS: Patients were assessed before surgery and 6, 12, and 24 months post-operatively. Evaluations involved interviews with parents and caregivers, conducted face-to-face or by telephone, using the Drooling Severity and Frequency Scales. Additionally, metrics such as the daily count of bib changes and the hourly frequency of saliva wiping were recorded. Quality-of-life assessments were performed before and after the surgical procedures. All complications associated with the interventions were carefully recorded. RESULTS: The study group consisted of 25 participants, with a median age of 6 years (range 2-17 years). Each participant was diagnosed with a neurological, metabolic, or genetic disorder. Evaluations were conducted periodically, culminating in a final follow-up at 24 months. The treatment demonstrated a 100% success rate at six months post-operation (25/25 patients), which slightly decreased to 96% at the 12-month mark (24/25 patients) and further to 84% by the 24-month follow-up (21/25 patients). Major complications were not observed. However, minor complications were reported in six patients (24%): three exhibited temporary facial swelling (12%), two encountered minor bleeding (8%), and one experienced excessive dryness (4%). CONCLUSIONS: The combination of Botulinum toxin-A injection 3 weeks prior to the four-duct ligation procedure demonstrated high success rates and substantially reduced the incidence of infectious and cosmetic complications. Consequently, this staggered approach to combination treatment is recommended for managing pediatric sialorrhea cases that are resistant to non-surgical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Faculty of Medicine, Istanbul Medipol University, Göztepe Mah. Atatürk Cad. No: 40/16, Beykoz, 34815, Istanbul, Turkey. omercalim@yahoo.com.
- Department of Otorhinolaryngology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey. omercalim@yahoo.com.
- Department of Otorhinolaryngology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Zitieren
APA
Calim, O. F., Polat, E., & Ozturan, O. (2025). Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09022-z
Vancouver
Calim OF, Polat E, Ozturan O. Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09022-z
BibTeX
@article{Calim2025,
author = {Calim, Omer Faruk and Polat, Emre and Ozturan, Orhan},
title = {Staggered botulinum toxin-a injections into parotid and submandibular glands prior to four-duct ligation for pediatric sialorrhea},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2025},
doi = {10.1007/s00405-024-09022-z}
}
EUVIMED